Hemodiafiltration may be associated with better cardiovascular and overall survival vs. high-flux hemodialysis for patients on dialysis, according to a European Renal Association consensus ...

Patients beginning lung cancer treatment demonstrated a high prevalence of atherosclerosis, which suggests that they may ...

The third annual national primary care scorecard spotlighted underinvestment in the field and the detrimental, worsening ...

In this video, Jennifer A. Woyach, MD, discusses two abstracts from ASH Annual Meeting and Exhibition that evaluated the use of immune therapies to treat chronic lymphocytic leukemia.

The FDA has approved label changes for once-monthly Sublocade, helping to reduce possible barriers to treatment initiation ...

In this video, Tanya Dorff, MD discusses evolving understanding of the underpinnings leading to risk for castration-resistant prostate cancer.

In this video, Tanya Dorff, MD discusses the greatest unmet needs in the treatment of castration-resistant prostate cancer.

In this video, Tanya Dorff, MD discusses the current state of the pipeline for developing castration-resistant prostate cancer treatments.

In this video, Tanya Dorff, MD discusses the latest advancements in the study and treatment of castration-resistant prostate cancer.

An expert discussed the rise of “Brotox” and what this means for practitioners as the proportion of men seeking cosmetic ...

Reducing glucocorticoid use in the treatment of giant cell arteritis and polymyalgia rheumatica — due to the steroid’s host ...

Women who reported snoring or having poor diet quality during their first trimester were more likely to develop a ...